Can GLP-1 Medication Affect Sex? What Science Shows About Libido & Sexual Function

The Complex Answer: Conflicting Effects Depending on the Medication

GLP-1 medications have dual and sometimes contradictory effects on sexual health—they can improve sexual function in some users while reducing libido and sexual pleasure in others. The difference often depends on which medication you take: tirzepatide (Mounjaro) shows different effects than semaglutide (Wegovy)

Positive Effects: Weight Loss Benefits Sexual Function

For men: Tirzepatide demonstrates significantly reduced erectile dysfunction risk compared to semaglutide, dulaglutide, and other diabetes medications. Men with type 2 diabetes on tirzepatide showed a 45% lower ED risk versus semaglutide and 30% lower versus sitagliptin. This improvement comes from enhanced blood flow, improved cardiovascular function, and hormonal optimization from weight loss.

For both genders: Significant weight loss (20-26%) improves sexual health through multiple mechanisms:

Enhanced blood flow to sexual organs (improved endothelial function)
Improved testosterone levels in men and hormonal balance in women
Reduced depression and anxiety, which impair sexual function
Increased confidence and self-esteem

Negative Effects: The Dopamine and Blood Flow Problem

Anorgasmia and reduced arousal: Several case reports document women experiencing anorgasmia (inability to reach orgasm) after starting semaglutide or liraglutide, with symptoms reversing after switching to tirzepatide. A 2024 peer-reviewed study noted this potential link

Proposed mechanisms:

Dopamine reduction: GLP-1 receptors in the hypothalamus regulate dopamine and norepinephrine—neurotransmitters critical for pleasure, motivation, and orgasm. GLP-1 activation may suppress these pathways
Vasoconstriction: GLP-1 agonists may cause smooth muscle vasoconstriction in genital tissues, reducing blood flow necessary for arousal and orgasm
Reward pathway modulation: GLP-1 medications decrease reward sensitivity broadly (explaining appetite suppression)—this extends to sexual pleasure

Why Tirzepatide May Differ from Semaglutide

Tirzepatide's dual GLP-1/GIP mechanism appears protective for sexual function. It activates GIP receptors at higher affinity than GLP-1, potentially offsetting GLP-1's dopamine-suppressing effects. This may explain why one patient with anorgasmia on semaglutide regained orgasm after switching to tirzepatide.

Low Libido: The Most Commonly Reported Issue

Social media analysis and user reports indicate decreased sexual desire is more common than erectile dysfunction with GLP-1 medications. Users describe:

Reduced interest in sexual activity despite good health
Delayed arousal
Less intense orgasms

However, these reports lack rigorous clinical validation.i

Key Variables Affecting Sexual Function

Individual factors:

Baseline sexual health status
Dose of medication
Speed of weight loss
Psychological factors (body image changes improve sex)i
Overall health improvements from weight loss

Exclude other causes as low sexual desire can be multifactorial:

Hormonal

Perimenopause/menopause, genitourinary syndrome of menopause (GSM) → dryness, burning, pain with sex, reduced arousal

Psychological

Stress, anxiety, depression, burnout, body image change (positive or negative)
Past sexual trauma

Medication effects

SSRIs/SNRIs (reduced desire, delayed orgasm/anorgasmia)
Some antihypertensives, hormonal contraception (variable), opioids

Relationship

Relationship strain, mismatch in desire, lack of safety/connection, life workload

Pain and pelvic health

Endometriosis/adenomyosis, dyspareunia, pelvic floor overactivity, vulvodynia—pain suppresses desire

Medical

Thyroid disease,anaemia/iron deficiency, diabetes/vascular disease, sleep apnoea, chronic inflammation

‍

Practical Recommendations

If experiencing sexual side effects:

Discuss with your prescriber immediately—dose adjustment or medication switching may help
Try tirzepatide if on semaglutide—emerging evidence suggests better sexual function
Prioritize cardiovascular exercise—improves blood flow and mood independently
Consider supplements supporting dopamine: L-tyrosine, vitamin D, or consultation with a sexual medicine specialist

‍

Screen for common contributors: mood, stress, relationship, sleep, alcohol, pain with sex, vaginal dryness.

Bottom Line

For men: Mounjaro (tirzepatide) improves erectile function compared to other GLP-1 medications, with 30-45% reduced ED risk.

For women and sexual pleasure generally: The evidence is mixed and conflicting. While weight loss and metabolic improvements support sexual health, GLP-1 activation may suppress dopamine-dependent pleasure pathways, causing anorgasmia or reduced arousal. Tirzepatide appears preferable to semaglutide based on limited case reports.

Honest assessment: More research is urgently needed on sexual side effects, as this area remains significantly understudied despite widespread medication use. Report any sexual changes to your healthcare provider—they may indicate a medication adjustment opportunity.

‍

Can GLP-1 Medication Affect Sex